One-hundred sixty-eight group B streptococcal (GBS) isolates from a Brazilian hospital were phenotypically and genotypically characterized. Isolates were recovered from human sources from April 2006 to May 2008 and classified as either invasive, noninvasive, or colonizing isolates. Classical methods for serotyping and antibiotic resistance profiling were employed. Clonal groups were also defined by pulsed-field gel electrophoresis (PFGE). Results showed that susceptibility to beta-lactam antimicrobials was predominant among the isolates. Only 4.7% were resistant to erythromycin and clindamycin. The erm(B) gene was widely detected in our GBS isolates, according to our phenotypic results (constitutive macrolide-lincosamide-streptogramin B [cMLS B ] resistance phenotype), and the erm(A) gene was also detected in some isolates. MLS B resistance was restricted to strains isolated from patients with noninvasive infections and carriers. Serotype Ia was predominant (38.1%), serotype IV isolates were found at a high frequency (13.1%), and few isolates of serotype III were identified (3%). Pulsed-field gel electrophoresis results revealed a variety of types, reflecting the substantial genetic diversity among GBS strains, although a great number of isolates could be clustered into two major groups with a high degree of genetic relatedness. Three main PFGE clonal groups were found, and isolates sharing the same PFGE type were grouped into different serotypes. Furthermore, in a few cases, isolates from the same patients and possessing the same PFGE type were of different serotypes. These findings could be related to the occurrence of capsular switching by horizontal transfer of capsular genes.
In the last 40 years, Streptococcus agalactiae (group B streptococcus [GBS]) has been described as an important pathogen in neonates and pregnant women. Vaginal colonization with GBS during pregnancy is significantly associated with infections in newborns and requires investigation (40, 46, 48) . Despite the reduction in the incidence of early-onset neonatal disease by using antimicrobial intrapartum prophylaxis, mortality and permanent disability rates caused by GBS continue to be significant. However, GBS has also emerged as an important pathogen in other patient groups, such as children, young adults with underlying medical conditions, and elderly individuals (40) . Penicillin is the drug of choice for prevention and treatment of GBS infections, which remain universally susceptible. Erythromycin and clindamycin are recommended when risks of anaphylaxis or therapeutic failure are present. However, resistance to erythromycin and clindamycin has increased in many countries in North America (2, 6, 16, 40) , Europe (21, 22, 42, 45) , and Asia (24) but not in Brazil (18, 50) and other Latin American countries (23, 35, 36) . Such a resistance profile is mainly due to two mechanisms: a methylasemediated target site modification and an active efflux pump (53) . In GBS, coresistance to macrolide, lincosamide, and streptogramin B (MLS B ) is due to methylases encoded by erm genes that modify a ribosomal target (57) . The MLS B resistance phenotype can be mediated by two classes of erm genes: (i) the widely predominant erm(B) determinant, which can be expressed either constitutively or inducibly and which is usually associated with high-level resistance (21) , and (ii) erm(TR), a member of the erm(A) subclass (44) , which is normally inducible and for which the level of resistance that it appears to confer depends on the contribution of drug efflux pumps (57) . In GBS, the presence of a drug efflux pump [a membranebound protein encoded mainly by the mef(A) gene] (32) is associated with a low-level resistance pattern and confers resistance only to 14-and 15-membered ring macrolides (M phenotype) (9) . Recently, mobile genetic elements have been identified in streptococcal species, including GBS carrying genes conferring macrolide resistance, suggesting that erythromycin and clindamycin resistance could be widely spread (43, 57) .
GBS can be subclassified into serotypes according to the immunogenic type of their polysaccharide capsule, and serotyping methods have been used to investigate GBS epidemiology in humans. There are nine well-known serotypes described (serotypes Ia, Ib, II, III, IV, V, VI, VII and VIII). The existence of a new serotype (serotype IX) has recently been proposed (52) . The predominant serotypes in the Western hemisphere are Ia, Ib, II, III, and V (39, 40); serotypes VI and VIII
RESULTS
Clinical data and patient profile. Patient profiles and their clinical data are summarized in Table 1 . Among nonpregnant patients, GBS strains were frequently isolated from urine (80.7%). Skin, bone, and joint tissue samples yielded few isolates (6%), and 9.6% of the cases were identified as bacteremia. In pregnant women, most of the GBS strains were isolated from urine (58.4%), but some isolates were also obtained from vaginal and rectal specimens (38.9%). The median age of the adult patients was 34 years.
Serotype analysis. Table 2 shows the number of isolates for each serotype group and their clinical manifestations. Colonizing isolates were present in higher numbers and were distributed in all serotypes. Serotype IV was commonly found in infections. Serotype Ia was found in several types of infections (bacteremia, meningitis, osteomyelitis, peritonitis, skin and urinary tract infections). A higher diversity of serotypes was observed in genital and rectal isolates, as well as urine and blood samples. Table 3 shows that in most age groups, serotype Ia was predominant. Different serotypes were mainly found in teenagers, nonpregnant, and pregnant adults. Eight GBS strains were obtained from newborns: four strains of three different serotypes were obtained both from newborns with early-onset infections and from newborns with late-onset infections.
Antimicrobial susceptibility and MLS B resistance profile. All GBS isolates were susceptible to penicillin, ampicillin, levofloxacin, and vancomycin. Resistance to erythromycin and clin- b Fourteen patients ages 13 to 19 years harbored 3 NI and 12 C isolates (1 patient included 2 C isolates); 58 patients ages 20 to 64 years harbored 7 NI and 55 C isolates (3 patients harbored 2 C isolates, and 1 patient harbored both an NI and a C isolate).
c Four patients ages 13 to 19 years harbored only colonizing isolates; 60 patients ages 20 to 64 years harbored 8 I, 19 NI, and 36 C isolates (2 patients harbored NI/C isolates, and 1 harbored only a noninvasive isolate); 16 patients Ͼ64 years of age harbored 4 I, 8 NI, and 4 C isolates.
d EOS, early-onset syndrome. All newborns with early-onset syndrome developed bacteremia.
e LOS, late-onset syndrome. Among the newborns with late-onset syndrome, one developed meningitis, one developed bacteremia, and one developed both meningitis and bacteremia. damycin was found in 4.7% of the samples (8 of 168) ( Table 4 ). All resistant GBS strains expressed the constitutive MLS B phenotype, and these possessed the erm(B) gene, as detected by PCR. The erm(A) and erm(B) resistance genes were found concomitantly in five of these isolates, and no mef(A) gene was found. Only serotypes II (n ϭ 3), IV (n ϭ 2), and V (n ϭ 3) were identified among resistant isolates.
Molecular typing by PFGE. Ninety-one distinct PFGE types were identified on the basis of dendrogram analysis. According to the data shown in Fig. 1 , isolates in 14 PFGE groups possessed above 80% similarity, and each group clustered at least two isolates. Of these, groups 2 and 14 clustered the highest number of GBS isolates. Also, among those PFGE groups, five included only GBS strains of the same serotype, and the remaining PFGE groups included GBS isolates of different serotypes. The other PFGE types showed less than 80% similarity and represented unrelated isolates.
For PFGE groups 2 and 14, clones (100% identity on the basis of PFGE analysis) with a minimum of 14 isolates are shown in greater detail in Fig. 1 , and those were designated PFGE clones A, B, and C, which accounted for 50 (29.8%) of the GBS isolates. Clone A comprised 14 isolates, 12 of serotype Ia, 1 of serotype V, and an NT isolate. Of those, 2 were invasive, 1 was noninvasive, and 11 were colonizing. Clone B contained 15 isolates, 13 of serotype Ia, 1 of serotype Ib, and 1 of serotype IV. Four isolates were noninvasive, and 11 were colonizing. Clone C consisted of 21 isolates, 8 of serotype IV and V, 3 of serotype III, 1 of serotype II, and 1 that was NT. Two strains were isolated from patients with invasive disease, 10 were collected from patients with noninvasive disease, and 9 originated from carriers. Except for serotypes Ia, IV, and V, for which clusters with 43, 10, and 8 isolates, respectively, could be seen in the dendrogram (data not shown), the other serotypes presented high degrees of genetic diversity.
PFGE analysis of the eight MLS B -resistant isolates resulted in their distribution into five PFGE types (data not shown). Four strains were clustered (Ͼ80% similarity), consisting of two clonal isolates of serotype IV and two of serotype V. Also, two strains of serotype II were clonal. The remaining two Nine patients yielded two clonal isolates each, as determined by PFGE analysis. In some cases, the pair of isolates from a patient belonged to different serotypes. From three patients, four isolates were recovered from the urinary tract at distinct times (one of serotype III and one of serotype IV from the first patient and one of serotype IV and one of V from the second one). Meanwhile, two isolates (one of serotype IV and one of serotype V) were recovered from rectal specimen culture and the urinary tract of the third patient at the same time. For the remaining six patients, a single serotype was present in each patient. In two cases, GBS samples recovered from newborns and their respective mothers were of the same serotype (serotype Ia) and also presented identical PFGE types.
DISCUSSION
Data collected from different geographic areas revealed considerable variation in the phenotypic and genotypic characteristics of GBS isolates (15, 18, 21, 22, 23, 24, 30, 31, 39, 42, 45) . In Brazil, data on the distribution of serotypes, as well as the molecular epidemiology of GBS isolates, are still scarce. In the present study, we investigated the phenotypic and genotypic properties for a collection of GBS strains isolated from community and hospitalized patients in southern Brazil.
A few cases of neonatal infections with no associated mortality were attributed to GBS infection in our study. However, GBS contributed to death when some underlying disease was present in both neonates and nonpregnant adults (data not shown). Previous studies have reported that GBS have emerged as important pathogens in children, young adults with underlying medical conditions, and elderly patients (40, 47) . During the study period, no child was included. A higher number of colonizing isolates was found in nonpregnant adults. However, although a small number of elderly patients (n ϭ 16) and newborns (n ϭ 7) has been included, most of the elderly patients and all of the neonates presented with infection. Furthermore, prematurity and low birth weight were frequently observed in neonates; and comorbidities such as cancer, diabetes mellitus, and renal disorders were found in elderly patients. Usually, newborns and patients with serious underlying diseases are at higher risk of bacterial colonization (19, 47) , and this would be consistent with our observations for those patient groups. (18, 23, 30, 31, 35, 40) , and it occurred in infection and colonizing isolates. Likewise, serotype II was also frequently seen in colonizing and infection isolates. In another Brazilian study, serotype Ib was often found in pregnant women (50) . Conversely, in our study a low number of isolates were of serotype Ib; however, some of those were causing early-onset and late-onset disease. This different finding is still unclear but confirms the higher degree of variability of serotypes in distinct regions even within the same country. Overall, serotype V was described elsewhere as an important serotype causing invasive infections in adults (21, 39, 40, 48) . In this study, serotype V was also identified among adult patients, but most of them consisted of colonizing isolates (15 of 21).
Our finding that showed that serotype III is of particular importance differed from the findings of previous studies, as it was frequently isolated in other countries (21, 30, 31, 35, 39, 40) and causes the majority of infections in neonates (47) . Only five GBS isolates from this study were of serotype III, and none of them were from neonates. A previous Brazilian study also isolated a lower number of GBS strains of serotype III from pregnant women (50) . Another study found a considerable number of strains of serotype III, but they were recovered from the milk of dairy cows (17) .
The rate of occurrence of serotype IV in different parts of the world is low (21, 38, 40) ; however, we isolated GBS expressing this capsular polysaccharide at a relatively high frequency (n ϭ 22; 13.1%). Furthermore, serotype IV was associated with late-onset disease and was the only serotype displaying a larger number of infectious isolates (Table 2 ). In contrast, serotype IV has not been described in previous Brazilian studies (18, 50) .
Previous studies reported occurrence rates of NT strains ranging from 1 to 18% (3, 21, 27, 50) . Our numbers (7.1%) included colonizing, noninvasive, and invasive isolates. Molecular serotyping methods would probably increase their typeability. However, a decreased capacity for capsular polysaccharide synthesis, noncapsulated phase variation, or cps gene cluster modification could prevent proper serotype identification (8, 27) . Our study confirms the high level of beta-lactam susceptibility of GBS (6, 40) . Neither penicillin-resistant nor penicillinintermediate GBS strains were found. Although full penicillin resistance has not been confirmed in GBS, some studies have reported a reduced susceptibility to penicillin (7, 13, 37) , but the overall penicillin susceptibility pattern remained unchanged (6, 36, 40, 45, 50) .
Erythromycin and clindamycin resistance was detected in 4.7% of the GBS isolates, and these strains were recovered from patients with noninvasive infections as well as carriers. This can be regarded as a low rate of incidence compared to incidence data from Asia, Europe, the United States, and Canada (6, 16, 24, 40, 42) ; but similar results were also found in other Latin American and Nordic countries (18, 23, 35, 36, 37 ). This could be attributed to the more intense clinical use of these antibiotics in Asia, Europe, the United States, and Canada. The presence of methylases encoded by erm genes is the most common MLS B resistance mechanism found (15, 58) . The erm(B) gene was detected in all resistant GBS isolates by PCR, and the erm(A) gene was also detected in a number of these isolates. The co-occurrence of these genes has been reported in previous studies. However, this combination does not change the MIC results and the presence of erm(B) alone has been reported to lead to higher MICs (4, 18, 20) . No strains were positive for mef(A). This gene has not been found in Brazilian GBS strains (18) .
The high degree of genetic diversity of the GBS isolates identified in this study is reflected in the results of the PFGE profiling analysis. Out of 91 distinct PFGE types, 14 PFGE groups with at least 80% similarity were identified. Of those, two PFGE groups (groups 2 and 14) represented 43.4% of all GBS isolates. From a study with 91 GBS strains, Gherardi et al. (21) reported that 52.7% of isolates belonged to four major clonal groups.
Molecular studies have reported that GBS strains of different serotypes would share more sequence similarities than isolates of the same serotype (56) . Our study found isolates of different serotypes belonging to the same clonal groups (A, B, and C) (Fig. 1) . This finding may be attributed to the horizontal transfer of capsular genes among GBS isolates of different serotypes, which could be driven by the evasion of the hostmediated immune response promoted by the genetic selection and maintenance of conserved structural motifs in the polysaccharide repeat unit of all capsular serotypes (8, 56) . We also observed similar PFGE types in serotypes Ia, IV, and V, while serotypes Ib, II, and III showed higher levels of heterogeneity. It has been found that the genetic variety is consistent with that found in previous studies in both large and small GBS populations (18, 21, 41) .
This study contained a GBS population recovered from a great diversity of patients who did not present epidemiological relationships. Also, no relevant associations among clinical data and phenotypic or genotypic characteristics were found.
Our GBS population included a considerable number of serotype IV isolates, in contrast to what is observed in most other countries. This fact highlights the need for further studies with larger numbers of isolates in different geographic areas. Variations in the relative occurrence of serotypes in different areas or countries could potentially compromise the effectiveness of more universal vaccines. Although we have shown a high degree of genetic diversity in isolates of the same serotype, many GBS isolates had high degrees of genetic similarity. An environmental origin could be the explanation for the spread of such isolates, since our patients were epidemiologically unrelated. We also observed that one GBS clone can express distinct serotypes in the same patient. Neither serotyping nor PFGE profiling alone would be enough to determine the relatedness of GBS isolates, since either typing method can fail to discriminate unrelated isolates or to group together related isolates. In this context, Tettelin et al. (56) reported that even other commonly used strain classification methods, such as multilocus sequence typing, do not reveal the real GBS genetic diversity evidenced for them by whole-genome analysis. Genomic sequencing of higher numbers of GBS strains representing the major disease-causing serotypes has been suggested to be an adequate tool for rational vaccine design (33) , and such approaches may also contribute to the understanding of the epidemiology of GBS.
